Tickers

ADTN — Ticker Eval done nvidia/nemotron-3-ultra-550b-a55b:free

Requested 2026-09-25 07:07:31.127498 UTC · finished 2026-09-25 07:10:52.238203 UTC

1. Composite Trajectory Verdict

The income statement and cash flow statement carry the most weight for assessing ADTN's trajectory because the company is in a revenue recovery and margin expansion phase where operating profitability and cash generation are the primary indicators of turnaround success.

Composite Trajectory: Improving

The 2025 results show significant improvement over 2024 across revenue (+17.5%), gross margin (+320 bps), operating loss (narrowed from -$427.6M to -$15.6M), net loss attributable to ADTRAN (narrowed from -$459.9M to -$45.7M), and operating cash flow (increased from $103.6M to $129.8M). The balance sheet shows improved liquidity (cash up to $95.7M from $76.0M) and a shift from short-term revolving debt to longer-term convertible notes, though retained deficit widened due to DPLTA-related accruals. The earnings and cash flow improvements dominate, supporting an improving composite trajectory.

2. Red Flags

  • Goodwill impairment of $297.4 million recognized in 2024 for Network Solutions reporting unit, indicating a significant prior overvaluation of assets (10-K 2025-12-31, Consolidated Statements of Loss).
  • Retained deficit widened to -$730.0 million in 2025 from -$688.8 million in 2024 despite a smaller net loss, driven by $9.3 million annual recurring compensation accrual under DPLTA (10-K 2025-12-31, Consolidated Statements of Changes in Equity).
  • DPLTA obligations: potential aggregate Exit Compensation of €303.9 million (~$357.0 million) plus ongoing Annual Recurring Compensation of ~$9.3 million per year, with appraisal proceedings extending until 2027 or beyond (10-K 2025-12-31, MD&A).
  • Material weakness in internal control over financial reporting identified by auditor as of December 31, 2025 (10-K 2025-12-31, Report of Independent Registered Public Accounting Firm).
  • Unearned revenue (current + non-current) increased 53% to $114.6 million in 2025 from $74.8 million in 2024, which may indicate billing ahead of revenue recognition (10-K 2025-12-31, Consolidated Balance Sheets).
  • Receivables factoring proceeds surged to $169.1 million in 2025 from $78.4 million in 2024, with factoring capacity of $40.0 million nearly fully utilized (10-K 2025-12-31, Note 2).
  • Trade policy/tariff uncertainty: U.S. tariff actions and retaliatory measures could materially alter input costs and customer demand (10-K 2025-12-31, MD&A).

3. Earnings Assessment

Earnings Trajectory: Improving

Overall Assessment: Revenue rebounded 17.5% year-over-year to $1,083.8 million in 2025 from $922.7 million in 2024, though still below the 2023 level of $1,149.1 million (10-K 2025-12-31, Consolidated Statements of Loss). Gross margin expanded to 38.3% in 2025 from 35.1% in 2024 and 28.8% in 2023, driven by reduced restructuring costs and favorable product mix (10-K 2025-12-31, MD&A). Operating loss narrowed dramatically to $15.6 million in 2025 from $427.6 million in 2024 (which included a $297.4 million goodwill impairment) and $223.7 million in 2023 (10-K 2025-12-31, Consolidated Statements of Loss). Net loss attributable to ADTRAN Holdings improved to $45.7 million in 2025 from $459.9 million in 2024 and $268.9 million in 2023 (10-K 2025-12-31, Consolidated Statements of Loss). SG&A and R&D expenses declined in absolute terms and as a percentage of revenue for the second consecutive year (10-K 2025-12-31, MD&A).

4. Cash Generation Assessment

Cash Trajectory: Improving

Overall Assessment: Net cash provided by operating activities increased to $129.8 million in 2025 from $103.6 million in 2024 and negative $43.0 million in 2023 (10-K 2025-12-31, Consolidated Statements of Cash Flows). The improvement was driven by a declining net loss (excluding goodwill impairment), lower depreciation and amortization, and favorable working capital changes including a $64.5 million reduction in inventory (10-K 2025-12-31, MD&A). Capital expenditures plus intangibles totaled $69.2 million in 2025, up from $65.2 million in 2024, resulting in free cash flow of approximately $60.6 million in 2025 versus $38.4 million in 2024 (10-K 2025-12-31, Consolidated Statements of Cash Flows). Cash and cash equivalents rose to $95.7 million at year-end 2025 from $76.0 million at year-end 2024 (10-K 2025-12-31, Consolidated Balance Sheets).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Overall Assessment: Total assets grew to $1,204.5 million in 2025 from $1,171.4 million in 2024 (10-K 2025-12-31, Consolidated Balance Sheets). Cash increased to $95.7 million from $76.0 million, and inventory decreased 17.5% to $215.7 million from $261.6 million (10-K 2025-12-31, Consolidated Balance Sheets). However, accounts receivable rose 18.3% to $210.7 million, and current liabilities jumped 23.3% to $361.9 million due to higher unearned revenue ($87.5 million vs $52.7 million) and a new $37.4 million deferred compensation liability (10-K 2025-12-31, Consolidated Balance Sheets). The company replaced $189.6 million of revolving credit borrowings with $201.3 million of convertible senior notes due 2030, extending debt maturities but increasing total debt to $218.0 million from $189.6 million (10-K 2025-12-31, Note 10 and Note 11). Redeemable non-controlling interest declined to $373.3 million from $422.9 million as 2.0 million Adtran Networks shares were tendered for Exit Compensation payments of $46.6 million (10-K 2025-12-31, MD&A). Retained deficit deepened to -$730.0 million from -$688.8 million due to net loss and DPLTA accruals (10-K 2025-12-31, Consolidated Statements of Changes in Equity).

6. Data Gaps

  • Quarterly financial statements for 2026 (10-Qs for Q1, Q2 2026) and 2025 (10-Qs for Q2, Q3 2025) were listed as provided but their detailed financial data is not present in the filings text, preventing intra-year trend analysis.
  • Full balance sheet for 2023 is not included in the XBRL data, limiting three-year balance sheet trends.
  • Segment-level operating income or margin is not disclosed, only revenue by segment.
  • Debt covenant compliance metrics (Consolidated Total Net Leverage Ratio, etc.) are stated as compliant but actual ratios are not provided.
  • Expected impact of BEAD program funding on future revenue is mentioned but not quantified.
  • Potential increase in DPLTA obligations from appraisal proceedings is not quantified beyond the current €303.9 million estimate.
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status